SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 27, 16:01
1083.45
40.45 (3.88%)
VOLUME 14,577
LIVE
NSE
May 27, 15:59
1084.65
43.15 (4.14%)
VOLUME 224,931
News on Divis Laboratories
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Divis Labs Q4 net seen up 10%, generic biz may support topline

5.39 pm | 27 May 2016 |  Source: CNBC-TV18

Topline growth may be on the back of increased capacity utilisation at new SEZ units and generic business. Analysts feel capacity utilisation rates sh...

Divis Laboratories' FY16 results on May 28, 2016

1.18 pm | 18 May 2016 |  Source: Moneycontrol.com

Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 28, 2016, inter alia, to consider ...

Short Aurobindo Pharma, buy Tata Chemical: Kunal Bothra 

2.07 pm | 13 May 2016 |  Source: CNBC-TV18

Kunal Bothra of LKP Securities is of the view that one may sell Aurobindo Pharma....

Short Divis Lab, buy IndusInd Bank: Rahul Shah 

1.20 pm | 09 May 2016 |  Source: CNBC-TV18

Rahul Shah of Motilal Oswal recommends shorting Divis Lab and advises buying IndusInd Bank....

Sell Arvind, PC Jeweller; buy Idea Cellular, Divis Lab: Sukhani 

9.42 am | 05 May 2016 |  Source: NEWS18.com

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Idea Cellular and Divis Lab and advises selling Arvind and PC Jeweller....

Six stocks that can give handsome returns on May 5 

8.50 am | 05 May 2016 |  Source: CNBC-TV18

Sameet Chavan of Angel Broking recommends buying Hindustan Unilever with a target of Rs 870 and advises selling Ashok Leyland with a target of Rs 98....

Bull's Eye: Buy Syngene, Dabur, Divis Lab, PFC; sell NMDC 

8.05 am | 29 Apr 2016 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com is of the view that one can buy ILandFS Investment Managers with a target of Rs 20 and Piramal Enterprises with a ta...

Bull's Eye: Buy BEML, Tata Elxsi, Syngene, Divis Lab, BEL

8.25 am | 28 Apr 2016 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com recommends buying Adani Port with a target of Rs 250 and Aban Offshore with a target of Rs 234....

Buy Divis Laboratories, PVR: Ashwani Gujral 

9.21 am | 22 Apr 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one can buy Divis Lab and PVR....

Buy Firstsource Solutions; sell TCS, Ambuja Cements: Gujral 

3.23 pm | 21 Apr 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one can buy Firstsource Solutions and advises selling TCS and Ambuja Cements....

Buy KPIT Tech, Divis Lab, PNB, BoB: Sudarshan Sukhani 

1.34 pm | 21 Apr 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy KPIT Tech, Divis Lab, Punjab National Bank and Bank of Baroda....

Allahabad Bank may test Rs 65, Divis Lab Rs 1083: Prakash Gaba 

9.33 am | 21 Apr 2016 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com is of the view that Allahabad Bank may test Rs 65 while Divis Lab may hit Rs 1083....

Buy Divis Labs; target of Rs 1260: Religare

1.31 pm | 28 Mar 2016 |  Source: Moneycontrol.com

Religare is bullish on Divis Labs has recommended buy rating on the stock with a target price of Rs 1260 in its research report dated March 15, 2016...

Motilal Oswal: neutral on Divis Labs; target of Rs 1180

2.09 pm | 10 Feb 2016 |  Source: Moneycontrol.com

Motilal Oswal has recommended neutral rating on Divis Labs with a target price of Rs 1180 in its research report dated February 8, 2016....

Buy Divis Labs; target of Rs 1305: Religare

5.31 pm | 09 Feb 2016 |  Source: Moneycontrol.com

Religare is bullish on Divis Labs Ind has recommended buy rating on the stock with a target price of Rs 1305 in its research report dated February 8, ...

Divis Labs Q3 misses estimates, profit rises 12% to Rs 247 cr

4.10 pm | 05 Feb 2016 |  Source: Moneycontrol.com

Operating profit (earnings before interest, tax, depreciation and amortisation) grew by 12.3 percent to Rs 322.3 crore and margin expanded by 150 basi...

Divis Labs Q3 profit seen up 26% on strong EBITDA, revenue

9.44 am | 05 Feb 2016 |  Source: CNBC-TV18

Operating profit in Q3 is likely to jump 28.2 percent to Rs 364 crore and margin may expand 240 basis points to 38.4 percent compared to year-ago peri...

1 2 3
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.